# Shanghai Institute Of Biological Products trials: 34 (2026)

ClinicalTrials.gov lists 34 trials with Shanghai Institute Of Biological Products as lead sponsor, 14 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Shanghai Institute Of Biological Products: 34 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/shanghai-institute-of-biological-products

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 34
- Recruiting or not yet: 14
- Read on: November 19, 2026

## Trials

The 25 newest of 34, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 23, 2026 | NCT07363837 | Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants | Shanghai Institute Of Biological Products | Phase 1/2 | Not yet recruiting | Respiratory Syncytial Virus (RSV) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363837) |
| January 8, 2026 | NCT07327398 | Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above | Shanghai Institute Of Biological Products | Phase 2 | Not yet recruiting | Influenza | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07327398) |
| December 24, 2025 | NCT07302256 | A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Influenza | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07302256) |
| November 28, 2025 | NCT07253675 | Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo | Shanghai Institute Of Biological Products | Phase 2 | Not yet recruiting | Monkeypox (Mpox) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07253675) |
| October 3, 2025 | NCT07205198 | A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects. | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Advanced Tumors | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07205198) |
| August 6, 2025 | NCT07106918 | A Clinical Trial of SIBP-A16 Injection in Healthy Adults | Shanghai Institute Of Biological Products | Early phase 1 | Recruiting | Respiratory Syncytial Virus (RSV) | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07106918) |
| May 25, 2025 | NCT06990464 | A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Advanced Solid Tumors | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06990464) |
| May 22, 2025 | NCT06985368 | A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Solid Tumor Malignancy | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06985368) |
| April 17, 2025 | NCT06932523 | A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals | Shanghai Institute Of Biological Products | Phase 1/2 | Recruiting | Herpes Zoster (HZ) | 645 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932523) |
| January 13, 2025 | NCT06771479 | A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Monkeypox | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06771479) |
| July 22, 2024 | NCT06512116 | A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Advanced Solid Tumor | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06512116) |
| May 3, 2024 | NCT06399003 | Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months | Shanghai Institute Of Biological Products | Phase 3 | Completed | Measles-Mumps-Rubella | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06399003) |
| April 2, 2024 | NCT06342349 | A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. | Shanghai Institute Of Biological Products | Phase 1 | Completed | Influenza | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06342349) |
| March 7, 2024 | NCT06298071 | A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Gout | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06298071) |
| March 7, 2024 | NCT06298058 | A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients. | Shanghai Institute Of Biological Products | Phase 1 | Recruiting | Advanced Solid Tumor | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06298058) |
| January 8, 2024 | NCT06194656 | Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma | Shanghai Institute Of Biological Products | Phase 2 | Recruiting | Head and Neck Squamous Cell Carcinoma | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06194656) |
| December 6, 2022 | NCT05639803 | A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults | Shanghai Institute Of Biological Products | Phase 1 | Completed | Herpes Zoster | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05639803) |
| August 8, 2022 | NCT05492591 | A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster | Shanghai Institute Of Biological Products | Phase 2 | Completed | Herpes Zoster | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05492591) |
| April 8, 2022 | NCT05318443 | A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer | Shanghai Institute Of Biological Products | Phase 3 | Completed | Non-squamous Non-small-cell Lung Cancer | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05318443) |
| March 31, 2022 | NCT05302388 | A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia | Shanghai Institute Of Biological Products | Phase 1 | Completed | Asymptomatic Hyperuricemia | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05302388) |
| January 24, 2022 | NCT05203601 | A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors. | Shanghai Institute Of Biological Products | Phase 1 | Completed | Tumor | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05203601) |
| December 17, 2021 | NCT05161845 | Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live | Shanghai Institute Of Biological Products | Phase 4 | Completed | Immunotoxicity, Vaccine | 1,068 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05161845) |
| December 15, 2021 | NCT05158777 | Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old | Shanghai Institute Of Biological Products | Phase 3 | Completed | Varicella | 2,480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05158777) |
| December 1, 2021 | NCT05138705 | Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years | Shanghai Institute Of Biological Products | Phase 4 | Completed | Influenza, Human | 380 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05138705) |
| April 27, 2020 | NCT04363359 | Clinical Trial of Quadrivalent Influenza Virus Split Vaccine | Shanghai Institute Of Biological Products | Phase 2 | Completed | Influenza | 1,980 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04363359) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 13 |
| Phase 1/2 | 4 |
| Phase 2 | 8 |
| Phase 3 | 6 |
| Phase 4 | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Recruiting | 11 |
| Not yet recruiting | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Influenza, Human | 8 |
| Herpes Zoster | 4 |
| Mpox, Monkeypox | 2 |
| Measles | 1 |
| Mumps | 1 |
| Rubella | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Neoplasms | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Neuralgia, Postherpetic | 1 |
| Premature Birth | 1 |
| Hyperuricemia | 1 |
| Gout | 1 |
| Chickenpox | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Occupational medicine clinics in the United States](https://specstream.ai/data/businesses/occupational-medicine-clinics/united-states)
- [B2B newspaper advertising companies in the United States](https://specstream.ai/data/businesses/b2b-newspaper-advertising-companies/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [Walk-in clinics in the United States](https://specstream.ai/data/businesses/walk-in-clinics/united-states)
- [Footwear wholesalers in the United States](https://specstream.ai/data/businesses/footwear-wholesalers/united-states)
- [Skylight installation companies in the United States](https://specstream.ai/data/businesses/skylight-installation-companies/united-states)
